Literature DB >> 25696481

Beta-blocking agents in congestive heart failure: for each heart failure patient?

C Klöpping, J H Kirkels, N de Jonge.   

Abstract

Entities:  

Year:  2005        PMID： 25696481      PMCID： PMC2497329     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  4 in total

1.  A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.

Authors:  Eric J Eichhorn; Michael J Domanski; Heidi Krause-Steinrauf; Michael R Bristow; Philip W Lavori
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

2.  Effect of carvedilol on survival in severe chronic heart failure.

Authors:  M Packer; A J Coats; M B Fowler; H A Katus; H Krum; P Mohacsi; J L Rouleau; M Tendera; A Castaigne; E B Roecker; M K Schultz; D L DeMets
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

3.  Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.

Authors:  Milton Packer; Michael B Fowler; Ellen B Roecker; Andrew J S Coats; Hugo A Katus; Henry Krum; Paul Mohacsi; Jean L Rouleau; Michal Tendera; Christoph Staiger; Terry L Holcslaw; Ildiko Amann-Zalan; David L DeMets
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

4.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Authors:  M Packer; M R Bristow; J N Cohn; W S Colucci; M B Fowler; E M Gilbert; N H Shusterman
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245
  4 in total
  1 in total

1.  Beta-blocker therapy in unstable severe heart failure, evidence or experience?

Authors:  C L Meuwese; J H Kirkels; N de Jonge; H M Nathoe; P A Doevendans; C Klöpping
Journal:  Neth Heart J       Date:  2013-01       Impact factor: 2.380
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.